FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048756775> ?p ?o ?g. }

• W3048756775 endingPage "55" @default.
• W3048756775 startingPage "44" @default.
• W3048756775 abstract "Rationale & ObjectivesAdiposity and physical fitness levels are major drivers of cardiometabolic risk, but these relationships have not been well-characterized in chronic kidney disease (CKD). We examined the associations of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), intrahepatic fat, and physical function with inflammation, insulin resistance, and adipokine levels in patients with CKD.Study DesignProspective cohort study.Setting & ParticipantsParticipants with stages 3-5 CKD not receiving maintenance dialysis, followed up at one of 8 clinical sites in the Chronic Renal Insufficiency Cohort (CRIC) Study, and who underwent magnetic resonance imaging of the abdomen at an annual CRIC Study visit (n = 419).PredictorsVAT volume, SAT volume, intrahepatic fat, body mass index, waist circumference, and time taken to complete the 400-m walk test (physical function).OutcomesMarkers of inflammation (interleukin 1β [IL-1β], IL-6, tumor necrosis factor receptor 1 [TNFR1], and TNFR2), insulin resistance (homeostasis model assessment of insulin resistance), and adipokine levels (adiponectin, total and high molecular weight, resistin, and leptin).Analytical ApproachMultivariable linear regression of VAT and SAT volume, intrahepatic fat, and physical function with individual markers (log-transformed values), adjusting for relevant covariates.ResultsMean age of the study population was 64.3 years; 41% were women, and mean estimated glomerular filtration rate was 53.2 ± 14.6 (SD) mL/min/1.73 m2. More than 85% were overweight or obese, and 40% had diabetes. Higher VAT volume, SAT volume, and liver proton density fat fraction were associated with lower levels of total and high-molecular-weight adiponectin, higher levels of leptin and insulin resistance, and lower high-density lipoprotein cholesterol and higher serum triglyceride levels. A slower 400-m walk time was associated only with higher levels of leptin, total adiponectin, plasma IL-6, and TNFR1 and did not modify the associations between fat measures and cardiometabolic risk factors.LimitationsLack of longitudinal data and dietary details.ConclusionsVarious measures of adiposity are associated with cardiometabolic risk factors. Physical function was also associated with the cardiometabolic risk factors studied and does not modify associations between fat measures and cardiometabolic risk factors. Longitudinal studies of the relationship between body fat and aerobic fitness with cardiovascular and kidney disease progression are warranted. Adiposity and physical fitness levels are major drivers of cardiometabolic risk, but these relationships have not been well-characterized in chronic kidney disease (CKD). We examined the associations of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), intrahepatic fat, and physical function with inflammation, insulin resistance, and adipokine levels in patients with CKD. Prospective cohort study. Participants with stages 3-5 CKD not receiving maintenance dialysis, followed up at one of 8 clinical sites in the Chronic Renal Insufficiency Cohort (CRIC) Study, and who underwent magnetic resonance imaging of the abdomen at an annual CRIC Study visit (n = 419). VAT volume, SAT volume, intrahepatic fat, body mass index, waist circumference, and time taken to complete the 400-m walk test (physical function). Markers of inflammation (interleukin 1β [IL-1β], IL-6, tumor necrosis factor receptor 1 [TNFR1], and TNFR2), insulin resistance (homeostasis model assessment of insulin resistance), and adipokine levels (adiponectin, total and high molecular weight, resistin, and leptin). Multivariable linear regression of VAT and SAT volume, intrahepatic fat, and physical function with individual markers (log-transformed values), adjusting for relevant covariates. Mean age of the study population was 64.3 years; 41% were women, and mean estimated glomerular filtration rate was 53.2 ± 14.6 (SD) mL/min/1.73 m2. More than 85% were overweight or obese, and 40% had diabetes. Higher VAT volume, SAT volume, and liver proton density fat fraction were associated with lower levels of total and high-molecular-weight adiponectin, higher levels of leptin and insulin resistance, and lower high-density lipoprotein cholesterol and higher serum triglyceride levels. A slower 400-m walk time was associated only with higher levels of leptin, total adiponectin, plasma IL-6, and TNFR1 and did not modify the associations between fat measures and cardiometabolic risk factors. Lack of longitudinal data and dietary details. Various measures of adiposity are associated with cardiometabolic risk factors. Physical function was also associated with the cardiometabolic risk factors studied and does not modify associations between fat measures and cardiometabolic risk factors. Longitudinal studies of the relationship between body fat and aerobic fitness with cardiovascular and kidney disease progression are warranted." @default.
• W3048756775 created "2020-08-18" @default.
• W3048756775 creator A5015656712 @default.
• W3048756775 creator A5015845150 @default.
• W3048756775 creator A5016894949 @default.
• W3048756775 creator A5019571004 @default.
• W3048756775 creator A5021944743 @default.
• W3048756775 creator A5026846209 @default.
• W3048756775 creator A5034955062 @default.
• W3048756775 creator A5040290418 @default.
• W3048756775 creator A5043993000 @default.
• W3048756775 creator A5047317486 @default.
• W3048756775 creator A5048299462 @default.
• W3048756775 creator A5048680434 @default.
• W3048756775 creator A5057195638 @default.
• W3048756775 creator A5058217417 @default.
• W3048756775 creator A5059771971 @default.
• W3048756775 creator A5060404770 @default.
• W3048756775 creator A5062288067 @default.
• W3048756775 creator A5065951270 @default.
• W3048756775 creator A5070158926 @default.
• W3048756775 creator A5074001023 @default.
• W3048756775 creator A5085929316 @default.
• W3048756775 creator A5086744652 @default.
• W3048756775 creator A5088560891 @default.
• W3048756775 creator A5088788555 @default.
• W3048756775 date "2021-01-01" @default.
• W3048756775 modified "2023-10-15" @default.
• W3048756775 title "Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD" @default.
• W3048756775 cites W1743590291 @default.
• W3048756775 cites W1848295836 @default.
• W3048756775 cites W1907653149 @default.
• W3048756775 cites W1916252988 @default.
• W3048756775 cites W1970394955 @default.
• W3048756775 cites W1971706983 @default.
• W3048756775 cites W1976474989 @default.
• W3048756775 cites W1989400130 @default.
• W3048756775 cites W1998458949 @default.
• W3048756775 cites W2005120853 @default.
• W3048756775 cites W2080406095 @default.
• W3048756775 cites W2081648262 @default.
• W3048756775 cites W2086225923 @default.
• W3048756775 cites W2100224608 @default.
• W3048756775 cites W2100478316 @default.
• W3048756775 cites W2109050350 @default.
• W3048756775 cites W2112481616 @default.
• W3048756775 cites W2112569577 @default.
• W3048756775 cites W2113723055 @default.
• W3048756775 cites W2119473645 @default.
• W3048756775 cites W2125262548 @default.
• W3048756775 cites W2127294600 @default.
• W3048756775 cites W2137670513 @default.
• W3048756775 cites W2139440406 @default.
• W3048756775 cites W2140493318 @default.
• W3048756775 cites W2160234571 @default.
• W3048756775 cites W2280219775 @default.
• W3048756775 cites W2513614033 @default.
• W3048756775 cites W2602540541 @default.
• W3048756775 cites W2616221862 @default.
• W3048756775 cites W2792284970 @default.
• W3048756775 cites W2942253286 @default.
• W3048756775 cites W2961683851 @default.
• W3048756775 doi "https://doi.org/10.1053/j.ajkd.2020.05.028" @default.
• W3048756775 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7752817" @default.
• W3048756775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32798563" @default.
• W3048756775 hasPublicationYear "2021" @default.
• W3048756775 type Work @default.
• W3048756775 sameAs 3048756775 @default.
• W3048756775 citedByCount "18" @default.
• W3048756775 countsByYear W30487567752021 @default.
• W3048756775 countsByYear W30487567752022 @default.
• W3048756775 countsByYear W30487567752023 @default.
• W3048756775 crossrefType "journal-article" @default.
• W3048756775 hasAuthorship W3048756775A5015656712 @default.
• W3048756775 hasAuthorship W3048756775A5015845150 @default.
• W3048756775 hasAuthorship W3048756775A5016894949 @default.
• W3048756775 hasAuthorship W3048756775A5019571004 @default.
• W3048756775 hasAuthorship W3048756775A5021944743 @default.
• W3048756775 hasAuthorship W3048756775A5026846209 @default.
• W3048756775 hasAuthorship W3048756775A5034955062 @default.
• W3048756775 hasAuthorship W3048756775A5040290418 @default.
• W3048756775 hasAuthorship W3048756775A5043993000 @default.
• W3048756775 hasAuthorship W3048756775A5047317486 @default.
• W3048756775 hasAuthorship W3048756775A5048299462 @default.
• W3048756775 hasAuthorship W3048756775A5048680434 @default.
• W3048756775 hasAuthorship W3048756775A5057195638 @default.
• W3048756775 hasAuthorship W3048756775A5058217417 @default.
• W3048756775 hasAuthorship W3048756775A5059771971 @default.
• W3048756775 hasAuthorship W3048756775A5060404770 @default.
• W3048756775 hasAuthorship W3048756775A5062288067 @default.
• W3048756775 hasAuthorship W3048756775A5065951270 @default.
• W3048756775 hasAuthorship W3048756775A5070158926 @default.
• W3048756775 hasAuthorship W3048756775A5074001023 @default.
• W3048756775 hasAuthorship W3048756775A5085929316 @default.
• W3048756775 hasAuthorship W3048756775A5086744652 @default.
• W3048756775 hasAuthorship W3048756775A5088560891 @default.
• W3048756775 hasAuthorship W3048756775A5088788555 @default.
• W3048756775 hasBestOaLocation W30487567751 @default.

• next